On January 31, 2023 Acorda Therapeutics, Inc. (NASDAQ: ACOR) reported that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will make a virtual presentation at the Sequire Biotechnology Conference on Thursday, February 2 at 3:00 p.m. ET (Press release, Acorda Therapeutics, JAN 31, 2023, View Source [SID1234626659]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: Acorda Therapeutics Presentation at the Sequire Biotechnology Conference
Date: Thursday, February 2, 2023
Time: 3:00 p.m. ET
Register to watch the presentation HERE.
A webcast of the presentation can also be accessed under "Investor Events" in the Investor section of the Acorda website at www.acorda.com, beginning Friday, February 3 by clicking the following link: View Source